Invention Grant
- Patent Title: High concentration olopatadine ophthalmic composition
- Patent Title (中): 高浓度奥洛他定眼科组合物
-
Application No.: US14304124Application Date: 2014-06-13
-
Publication No.: US09533053B2Publication Date: 2017-01-03
- Inventor: Daniel A. Gamache , Laman Alani , Malay Ghosh , Francisco Javier Galan , Nuria Carreras Perdiguer , Onkar N. Singh
- Applicant: Alcon Research, Ltd.
- Applicant Address: US TX Fort Worth
- Assignee: Alcon Research, Ltd.
- Current Assignee: Alcon Research, Ltd.
- Current Assignee Address: US TX Fort Worth
- Agent Scott A. Chapple
- Main IPC: A61K31/335
- IPC: A61K31/335 ; A01N43/02 ; A61K47/00 ; A61K47/40 ; A61K9/00 ; A61K47/32 ; A61K9/08 ; A61K47/48 ; C08B37/16 ; C08L5/16 ; A61K47/10 ; B82Y5/00
Abstract:
The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis, particularly late phase symptoms of ocular allergic conjunctivitis.
Public/Granted literature
- US20140296328A1 HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION Public/Granted day:2014-10-02
Information query
